bioRxivCancer BiologyPreprint
Hypermetabolic state is associated with circadian rhythm disruption in mouse and human cancer cells
D. M. Iascone, X. Zhang, P. Bafford, C. Mesaros, Y. Sela, S. Hofbauer, S. L. Zhang, K. Cook, P. Pivarshev, B. Stanger, S. A. Anderson, C. V. Dang, A. Sehgal
Abstract
Crosstalk between cellular metabolism and circadian rhythms is a fundamental building block of multicellular life, and disruption of this reciprocal communication could be relevant to degenerative disease, including cancer. Here, we investigated whether maintenance of circadian rhythms depends upon specific metabolic pathways, particularly in the context of cancer. We found that in adult mouse fibroblasts, ATP levels were a major contributor to overall levels of a clock gene luciferase reporter, although not necessarily to the strength of circadian cycling. In contrast, we identified significant metabolic control of circadian function in an in vitro mouse model of pancreatic adenocarcinoma. Metabolic profiling of a library of congenic tumor cell clones revealed significant differences in levels of lactate, pyruvate, ATP, and other crucial metabolites that we used to identify candidate clones with which to generate circadian reporter lines. Despite the shared genetic background of the clones, we observed diverse circadian profiles among these lines that varied with their metabolic phenotype: the most hypometabolic line had the strongest circadian rhythms while the most hypermetabolic line had the weakest rhythms. Treatment of these tumor cell lines with bezafibrate, a peroxisome proliferator-activated receptor (PPAR) agonist shown to increase OxPhos, decreased the amplitude of circadian oscillation in a subset of tumor cell lines. Strikingly, treatment with the Complex I antagonist rotenone enhanced circadian rhythms only in the tumor cell line in which glycolysis was also low, thereby establishing a hypometabolic state. We further analyzed metabolic and circadian phenotypes across a panel of human patient-derived melanoma cell lines and observed a significant negative association between metabolic activity and circadian cycling strength. Together, these findings suggest that metabolic heterogeneity in cancer directly contributes to circadian function, and that high levels of glycolysis or OxPhos independently disrupt circadian rhythms in these cells.
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis
J. Cazarin, R. E. DeRollo, … B. J. Altman·bioRxiv·Jan 3, 2023
- The Circadian Clock is Disrupted in Pancreatic Cancer
P. B. Schwartz, M. Nukaya, … S. Ronnekleiv-Kelly·bioRxiv·Nov 1, 2022
- Circadian Oscillations Persist in Low Malignancy Breast Cancer Cells
Sujeewa S. Lellupitiyage Don, Hui-Hsien Lin, … Michelle E. Farkas·Cell CyclePeer-reviewed·Jul 30, 2019
- NADH dehydrogenase reverses dietary and clock metabolic syndrome
Chelsea Hepler, Nathan J. Waldeck, … Joseph T. Bass·bioRxiv·Oct 22, 2025
- Chronic Jetlag Accelerates Pancreatic Neoplasia in Conditional Kras-Mutant Mice
P. B. Schwartz, M. T. Walcheck, … S. M. Ronnekleiv-Kelly·bioRxiv·Jul 18, 2022
- Why the tumor cell metabolism is not that abnormal
P. Jacquet, A. Stephanou·bioRxiv·Dec 4, 2019